Atara Biotherapeutics Inc

XNAS:ATRA

4.91

-0.21 (-4.10%)

7:48:35 PM EDT: $4.99 +0.08 (+1.63%)

Market Cap (Intraday)	38.51M
Current PE	1.18
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.35 Million
Adjusted EPS	-$0.33

See more estimates

10-Day MA	$5.46
50-Day MA	$5.50
200-Day MA	$10.88

See more pivots

Atara Biotherapeutics Inc Stock, XNAS:ATRA

1280 Rancho Conejo Boulevard, Suite 200, Thousand Oaks, California 91320

United States of America

Phone: +1.805.623.4211

Number of Employees: 153

http://www.atarabio.com

Description

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.